Clinical trial
A Study of the Effectiveness and Safety of Topiramate for the Prevention of…
NCT00253175 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00253175 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine |
| Official title | A Comparison Of The Efficacy And Safety Of Topamax® (Topiramate) Tablets Versus Placebo For The Prophylaxis Of Migraine |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vascular Headaches, Migraine |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 211 |
| Start date | Oct 1, 2000 |
| Completion | Dec 1, 2001 |
| First posted | Nov 15, 2005 |
| Last update posted | Apr 28, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: